Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
Mitchell
Article
As Crises Linger, U.S. Hospitals Continue to Face Headwinds
This article is authored by guest blogger, Jill Harris, Senior Director, Network Development at Coventry, a part of Mitchell | Genex | Coventry
Workers' Comp
Article
A Shot in the Arm to Move Claims Forward During COVID
Vaccination allows Genex case managers more opportunities for vital interaction to improve case outcomesAs frontline workers, field case m
Mitchell
Article
Current Used Vehicle Market Conditions: Q4 2020
December 2020 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global.
Auto Casualty
Article
Drug of the Month: Insights Into COVID-19 Vaccines and Workers' Comp
COVID-19 vaccination efforts continue to progress, after the
Mitchell
Article
The Evolution of Claims Automation
COVID-19 has hastened the pace of digital transformation in many industries, including auto insurance.
Mitchell
News Release
Mitchell Introduces New Alternative for AI-Enabled Claims Processing Through Collaboration with Claim Genius
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the